Latest News of NTLA
Intellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History
Intellia Therapeutics is hosting two investor events in November 2024, including the release of third quarter financial results and new clinical data for nexiguran ziclumeran. This news comes amidst o...
Intellia reports positive data from Phase II study of NTLA-2002 for HAE
Intellia Therapeutics announces positive results from Phase I/II trial of NTLA-2002, a CRISPR-based gene therapy for hereditary angioedema. Promising reduction in monthly attack rates and potential fo...
Xander Schauffele and Patrick Cantlay forming a cornerstone for American team golf
Xander Schauffele and Patrick Cantlay's success in team competitions like the Ryder Cup and Presidents Cup signals a new era for American golf....
-
Patrick Cantlay is the big winner of Presidents Cup week
By The New York Times | 1 month agoPatrick Cantlay's clutch play led the U.S. team to victory in the Presidents Cup. Known as "Patty Ice," he excels in team events, displaying a unique ability to shine under pressure and defeat top pla...
-
We're Keeping An Eye On Intellia Therapeutics' (NASDAQ:NTLA) Cash Burn Rate
By Yahoo! Finance | 3 months agoEven if a business is losing money, shareholders can still profit by investing in a good business at the right price. Intellia Therapeutics has a 23-month cash runway with $791m cash. Despite rising c...